Cardiovascular-kidney-liver-metabolic-health:a population-based study on the prognostic impact of the coexistence of metabolic dysfunction-associated steatotic liver disease and chronic kidney disease
R Goh, J Koh, A Intaran, Y H Chin et autres
Abstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD) and chronic kidney disease (CKD) are emerging non-traditional cardiovascular risk factors. However, the clinical characteristics and prognostic importance of coexistent MASLD and CKD in the general population remain understudied. This study aims to strengthen …
sg, us (code pays fourni par la source)
1 citation
European Heart Journal